BiotechTube
Home/NeuroPace/David Greene, Ph.D.
DG

David Greene, Ph.D.

Chief Technology Officer

NeuroPace

Therapeutic Areas

EpilepsyNeurological Disorders

NeuroPace Pipeline

DrugIndicationPhase
RNS System - NAUTILUS StudyIdiopathic Generalized Epilepsy (IGE)Pivotal Trial
RNS System - Long-Term Post-Approval StudyDrug-Resistant Focal EpilepsyPost-Market
nSight PDMSEpilepsy Data ManagementCommercial

Leadership Team at NeuroPace

JB
Joel Becker
Chief Executive Officer
RK
Rebecca Kuhn
Chief Financial Officer
MM
Martha Morrell, M.D.
Chief Medical Officer
FF
Frank Fischer
Chairman of the Board
View full NeuroPace profile